|
|
||||||||
1 Cardiology Unit, Department of Medicine, and 2 Department of Molecular Physiology and Biophysics, University of Vermont, Burlington, Vermont 05405
| |
ABSTRACT |
|---|
|
|
|---|
Alteration of troponin T (TnT) isoform expression has been reported in human and animal models of myocardial failure. The two adult beef cardiac TnT isoforms (TnT3 and TnT4) were isolated for comparative functional analysis. Thin filaments were reconstituted containing pure populations of the isoforms. The in vitro motility assay was used to directly compare the effect of the two TnT isoforms on force and unloaded shortening as a function of free calcium. We found no significant differences between the two isoforms in terms of calcium sensitivity, cooperativity, or maximal activation (velocity and force) as assessed in a fully calcium-regulated system. Activation by myosin strong binding was similar for thin filaments containing either of the two TnT isoforms. Whereas maximally activated velocity and cooperativity was depressed at pH 6.5, no difference between thin filaments containing the two isoforms was detected. From the small magnitude of the TnT isoform shifts detected in myocardial failure and the lack of significant mechanical effect detected in the motility assay, variable TnT isoform expression is unlikely to be any functional significance in heart failure.
thin filament; myocardial failure; in vitro motility
| |
INTRODUCTION |
|---|
|
|
|---|
TROPONIN T (TnT) isoform shifts are observed in left ventricular hypertrophy and myocardial failure in mammalian models and humans (2, 7, 18, 39). These isoform shifts have been correlated with alterations in myocardial function as illustrated in human cardiac failure where expression of the fetal isoform (TnT4) is increased from 4% to 12% relative to TnT3, the predominant isoform in adult human myocardium (2). Specific isoform expression is the result of variable exon inclusion in the NH2-terminal segment of the protein with TnT3 and differing from TnT4 by the inclusion of one exon (5 amino acids). To date, there has been no proof of a cause and effect relationship between TnT isform shifts and altered contractile function. The two actin-associated proteins troponin and tropomyosin regulate the activation of muscle. TnT, the tropomyosin binding subunit of the troponin complex, contains a globular COOH-terminus and a long NH2-terminal tail. The globular portion of TnT binds to troponin C (TnC; the calcium binding subunit), troponin I (TnI; the inhibitory subunit), and tropomyosin in a calcium-dependent manner. The NH2-terminus of TnT is highly charged and binds to tropomyosin in a calcium-independent manner, thus providing a tether for the entire troponin complex to the thin filament during muscle activation. The NH2-terminal segment of TnT binds at the NH2-terminal/COOH-terminal overlap of two adjacent tropomyosin molecules. The overlap of adjacent tropomyosins is felt to be a critical component of thin filament-mediated cooperative activation. Excimer fluorescence studies have demonstrated enhanced cooperativity of the thin filament in the presence of troponin compared with actin and tropomyosin alone (8). This enhanced cooperativity is felt to be largely an effect of the NH2-terminal segment of TnT, which enhances the binding of the tropomyosin to actin (12) and thus likely facilitates the communication of movement between adjacent tropomyosins with thin filament activation. The fact that the NH2-terminal segment of TnT is 1) highly charged, 2) overlies the overlap of adjacent tropomyosins, and 3) may impact the cooperativity of the thin filament, raises the possibility that even a small change in isoform content could significantly alter the cooperative activation of the thin filament.
To delineate the consequence of variable TnT isoform expression, we isolated the two adult beef TnT isoforms and characterized their effect on thin filament function. The sequence differences between the adult beef isoforms are nearly identical to those found between the two human TnT isoforms expressed in myocardial failure. To directly test the effect of different TnT isoforms on thin filament function, TnT isoforms were isolated and subsequently reconstituted with troponin C and troponin I. Functional differences between TnT isoforms were investigated by using calcium-regulated thin filaments in the in vitro motility assay.
| |
METHODS |
|---|
|
|
|---|
Contractile Proteins
Myosin was isolated from chicken pectoralis skeletal muscle as previously reported (22). Skeletal myosin was used because it has proven to be more functionally stable than cardiac myosin once isolated and thus allows for greater consistency between experiments (35). Actin was isolated from chicken pectoralis skeletal muscle by standard techniques (24) and stored in filamentous form on ice. Tropomyosin was isolated from rabbit skeletal muscle by the methods of Smillie (28), with further purification by hydroxyapatite chromatography. Isolation of the troponin subunits and separation of the TnT isoforms was as follows. Isolation from beef cardiac ether powder was performed as per the method of Potter (26) with minor modifications. In brief, crude cardiac troponin extract was initially run over an Uno-S cation exchange column (Bio-Rad) after equilibration [6 M urea, 50 mM citrate (pH 6.0), 1 mM EDTA and 0.1 mM dithiothreitol (DTT)]. Protein elution was achieved using a linear NaCl gradient. This step resulted in partial purification of TnC, TnI, and TnT. Further purification of TnC and TnI was achieved with the use of an anion exchange column (Uno-Q, Bio-Rad).Final purification and separation of the two adult bovine TnT isoforms
were achieved using the final TnT purification protocol (26) with the exception that the Uno-Q anion exchange
column (Bio-Rad) was used. This protocol allowed nearly complete
separation of the two TnT isoforms with TnT4 eluting at
~160 mM KCl and TnT3 eluting at ~190 mM KCl.
Reconstitution of Tn from its subunits was as per Guo et al.
(9). Troponin subunit reconstitution was followed by gel
filtration chromatography. The purification and reconstitution resulted
in troponins that demonstrate stoichiometric representation of the
three subunits (Fig. 1). Proteins were
snap-frozen and stored at
80°C in a solution composed of (in mM)
100 KCl, 10 3-(N-morpholino)propanesulfonic acid (pH 7.0),
0.5 CaCl2, and 1 DTT until use. Protein concentrations were
determined from their molecular weights and extinction coefficients
(33). Thin filaments were reconstituted as previously
described (13). Thin filaments were then labeled with
rhodamine-phalloidin at a 1:1 actin-to-phalloidin ratio in low-salt
buffer (in mM: 25 KCl, 25 imidazole, 5 MgCl2, 10 DTT, and 2 EGTA, pH 7.4) and stored overnight a 4°C before use in the in vitro
motility assay. The actin binding protein
-actinin (Sigma; St.
Louis, MO) was dialyzed into the above low-salt buffer before use.
|
To determine whether functional differences existed between reconstituted thin filament and isolated native thin filaments, native thin filaments were isolated from frozen bovine left ventricles as per the method of Lehman et al. (19) with the exception that the purification protocol was terminated after the 150-min centrifugation step. The final pellet was raised in low-salt buffer. Native thin filament protein concentration was determined with a protein assay (Bio-Rad) and microplate reader using actin as the standard. Native thin filaments were labeled with rhodamine-phalloidin as above.
In Vitro Assays
Motility. The in vitro motility assay was employed to assess the contribution of the two adult beef cardiac TnT isoforms on calcium-sensitive unloaded shortening and isometric force. The in vitro motility assay has been previously described in detail (13, 36). Free calcium was varied in the final motility solution (i.e., pCa 10-4.5) through the use of the public domain software called Bound and Determined (6). All experiments were performed at 30°C. As variable TnT expression occurs in perinatal development, thin filament calcium-sensitive motility was assessed under slightly acidic conditions to mimic a potential physiological condition of the perinatal period. In this set of experiments the final motility solutions were adjusted to pH 6.5 by using the above software. To determine the effect of myosin strong binding on thin filament activation, velocity as a function of myosin concentration on the motility surface was determined. In these experiments the thin filaments were calcium activated with the final motility solution containing 10 µM free calcium (i.e., pCa 5).
To assess whether
-actinin binding to actin affected either thin
filament regulatory function or actomyosin interactions, control
experiments were designed in which
-actinin was incubated overnight
with reconstituted thin filaments (molar ratios of 1:4 and 1:2
-actinin to actin, respectively). The pCa-velocity relation of these
thin filaments containing
-actinin was determined under conditions
in which no
-actinin was bound to the motility surface (i.e.,
unloaded conditions). The presence of
-actinin on the thin filament
did not affect calcium-sensitive regulation nor maximal unloaded
shortening (data not shown), demonstrating that the binding
-actinin
to actin does not affect thin filament function. Thus
-actinin
appears to be a suitable agent to assess isometric force in the
motility assay (discussed in Isometric Force)
because it does not artifactually affect the mechanical properties of the contractile proteins.
In the in vitro motility assay, individual thin filaments were observed
moving across the myosin-coated surface. Thin filament velocity was
determined using the Motion Analysis System (Santa Rosa, CA) as
previously described (14). Velocity of thin filaments as a
function of pCa was assessed for thin filaments containing either the
TnT3 or TnT4 isoform. Typically >250
individual filament velocities were averaged to determine the mean
velocity-pCa data point for each TnT isoform. A nonlinear least-squares
regression was fit to the data (SigmaPlot, Jandel Scientific) by using
a four-parameter Hill equation (15). Statistical
comparison was performed from the parameters of the fit by use of
an unpaired t-test. All values are expressed as means ± SE.
Isometric Force
Relative isometric force was determined for thin filaments containing the two cardiac TnT isoforms and bovine cardiac native thin filaments by using
-actinin as an internal load. In brief, myosin
was adhered to the nitrocellulose-coated coverslip as described above.
-Actinin was then attached to the coverslip surface (15-100 µg/ml in low-salt buffer), followed by a bovine serum albumin wash
(0.5 mg/ml in low-salt buffer). Reconstituted thin filaments (10-20 nM) were then added to the motility surface. Motility was initiated with the addition of the motility buffer as described above.
As
-actinin avidly binds to actin, the motion of the thin filament
is impeded by the
-actinin adhered to the surface. The load placed
on a thin filament is a function of the relative concentrations of the
force generator (myosin) and the motion inhibitor (
-actinin). The
amount of
-actinin adhered to the motility surface was gradually increased until motility was completely arrested, thus indicating an
isometric state. As reported by Haeberle (10), image
processing with background subtraction was employed to aid in this
determination, because this technique is exquisitely sensitive to the
slightest thin filament movement. Whereas thin filaments arrested on
the motility surface may demonstrate a small amount of reptation (i.e., Brownian motion) under isometric conditions, no net movement of thin filaments was observed over time. Relative isometric force was
then defined as the minimum amount of
-actinin needed to completely
arrest thin filament motility. Others (4) have recently used this approach with consistent results. To further test the validity of this technique, force as a function of skeletal myosin concentration on the motility surface (12.5 to 100 µg/ml) was determined for actin. In previous experiments using the microneedle technique, we have demonstrated that for actin alone, force increases as a linear function of the myosin concentration on the surface (37). Force as a function of calcium activation was
determined for thin filaments containing TnT3 and
TnT4 isoforms, as well as bovine cardiac native thin
filaments. Force data were fit and statistical significance was
determined as described above for the velocity data.
| |
RESULTS |
|---|
|
|
|---|
Complete isolation of the two adult beef cardiac TnT isoforms and
reconstitution with TnI and TnC was achieved as demonstrated by
SDS-PAGE (Fig. 1). Isolation and reconstitution of the thin filament
proteins had no apparent effect on either thin filament regulation or
function. Full calcium regulation of the reconstituted thin filaments
was demonstrated by the pCa-velocity relation (Fig. 2A), in which reconstituted
thin filaments were nonmotile at pCa 10, cooperatively activated at
transitional calcium concentrations, and fully activated at high
calcium concentrations. Furthermore, the velocity thin filaments that
underwent subunit isolation and reconstitution was similar to native
thin filaments isolated intact from the sarcomere (Fig. 2B;
Table 1). Thin filaments
containing TnT3 demonstrated no difference in calcium
sensitivity (pCa50), cooperativity (Hill coefficient), or
maximal activation (Vmax) compared with thin
filaments containing TnT4 (Fig. 2A; Table 1).
|
|
To assess thin filament activation via myosin strong binding, the
myosin concentration on the motility surface was varied by altering the
myosin concentration in the labeling solution (37). Under
maximally calcium-activated conditions (pCa 5), thin filament velocity
as a function of surface myosin concentration was determined (Fig.
3). Velocity of thin filaments was
markedly slowed at low myosin concentrations and increased as a
cooperative function of surface myosin concentration (i.e., the number
of myosin cross bridges interacting with the thin filament). No
difference in myosin strong binding activation was seen for thin
filaments containing either of the TnT isoforms. To explore the
possibility that myosin activation of the thin filament is more
pronounced at submaximal calcium concentrations, the above experiments
were repeated at pCa 6.25. No difference was found for the two beef TnT
isoforms (data not shown), indicating that myosin activation of the
thin filament is not differentially affected.
|
TnT isoforms are differentially expressed in perinatal development,
raising the possibility that the TnT isoforms could function differently in an acidic environment. Velocity-pCa experiments were
performed at pH 6.5 (Fig. 4). At pH 6.5 (Fig. 4) there was a reduction in maximal velocity (3.2 ± 0.3 and
3.1 ± 0.4 µm/s for TnT3 and TnT4,
respectively; P < 0.001) compared with velocities at
pH 7.4 (Table 1). There was also a reduction in the Hill
coefficient for thin filaments at the lower pH (1.3 ± 0.3 and
1.1 ± 0.3 for TnT3 and TnT4,
respectively; P < 0.001). No change in calcium sensitivity was observed (6.45 ± 0.08 and 6.42 ± 0.12 for
TnT3 and TnT4, respectively; P = not significant). Irrespective of the difference in maximal
activation and cooperativity at pH 6.5, compared with pH 7.4, no
functional differences between the two TnT isoforms were detected at pH
6.5.
|
To determine whether the
-actinin method is capable of detecting the
changes in force generation that result from small changes in the
number of myosin molecules on the surface, force as a function of
myosin concentration on the surface was determined. Force increased as
a linear function of the myosin concentration on the surface (Fig.
5; r2 = 0.99)
similar to previous force data using the microneedle technique under
identical experimental conditions (37). These results
indicate that this method is comparable to the microneedle technique in
measuring force.
|
Force as a function of calcium activation was determined for myosins
interacting with thin filaments containing either TnT3 or
TnT4 (Fig. 6A;
Table 1). Force increased as a cooperative function of the ambient
calcium concentration and is similar to isolated intact native thin
filaments (Fig. 6B; Table 1). The Hill coefficient was not
different for the two TnT isoforms and is similar to that reported in
skinned cardiac fiber studies (15). Thin filament calcium
sensitivity for force was similar for thin filaments containing
TnT3 and TnT4, and no difference in maximally activated force was observed.
|
| |
DISCUSSION |
|---|
|
|
|---|
Alterations in TnT isoform expression occur during perinatal development and in myocardial hypertrophy and failure. The transition to myocardial failure is associated with reexpression of a fetal gene program. Associated with this program is increased expression of the fetal isoform of TnT. One of the hallmarks of myocardial failure is a reduction of mehanical performance as measured by a decrease in ventricular ejection fraction and cardiac output. Skinned fiber studies have demonstrated that a substantial proportion of the deficit found in failing myocardium can be directly linked to an alteration in sarcomere function. Which specific changes at the contractile protein level are responsible for the functional alterations in heart failure are not well understood. A shift in TnT isoform expression has been proposed as a contributor to myofilament dysfunction and has been correlated with depression in ventricular and myocyte function in heart failure (2, 3, 18). This correlation has not been consistent, however, because shifts in TnT isoform expression are not always found in heart failure (17) and are reported in ventricular hypertrophy with no change in contractile function (7). Therefore, a causal relation has not been established between TnT isoform expression and contractility in myocardial failure, because a direct functional assessment of the effect of cardiac TnT isoform variation on contractile performance heretofore has not been performed.
The two adult beef TnT isoforms differ by the inclusion of a single exon (exon 4; encoding amino acids EAAEE) in TnT3 but not in TnT4 (20). The beef cardiac TnT isoforms have distinct parallels with the two TnT isoforms expressed in human myocardial failure. Like the beef TnT isoforms, human TnT isoforms differ by the inclusion of exon 4 (encoding amino acids EAAVE) in TnT3 but not TnT4 (1). The process of extraction and isolation of the TnT isoforms yielded pure populations of the two isoforms (Fig. 1). Reconstitution of the isoforms with the full complement of thin filament protein resulted in restoration of thin filament function, as was evident by complete inhibition of movement at low calcium concentrations and an activational plateau at higher calcium concentrations.
The NH2-terminal binding overlap of TnT with two adjacent tropomyosins is felt to be integral in the cooperative activation of the thin filament. With the "hypervariable" region of TnT being in the NH2-terminal segment, it is conceivable that TnT isoforms may differentially affect thin filament cooperative activation. This could occur through affecting the "communication" of movement between two adjacent tropomyosins. Specifically, Geeves and Lehrer (8) have demonstrated that the number of myosin binding sites exposed (i.e., cooperative unit size) with myosin binding increases twofold with the addition of troponin to actin-tropomyosin. Presumably, this increase in unit size is predominantly the result of the calcium independent binding of the NH2-terminus of TnT binding to adjacent tropomyosins. Overexpression of fast skeletal TnT in the mouse heart resulted in a modest change in the cooperative activation of the thin filament, whereas no change in calcium sensitivity or maximally activated force was demonstrated (15). In contrast, we found no difference in cooperativity between the two beef cardiac isoforms as determined by the Hill coefficient (Table 1). Similarly, no difference between the two isoforms was discernable at submaximal (pCa50) or maximal calcium activation for both unloaded shortening and isometric force. Tobacman and Lee (34) investigated the effect of the two adult beef TnT isoforms on calcium-sensitive ATPase and demonstrated a small increase in calcium sensitivity (0.1 pCa units) for TnT4 relative to TnT3. Our results reveal a small shift in the calcium sensitivity of force (Table 1), but this did not achieve statistical significance (P > 0.2).
Because the thin filament is activated by both calcium and by myosin strong binding, TnT isoform variation could affect thin filament activation through the cooperative effects of myosin strong binding. Previous estimates indicate in that in the in vitro motility assay at 100 µg/ml myosin concentration ~54 myosin cross bridges are available per micron of actin filament (11). Assuming 5.5 nm per actin monomer would yield an estimate of ~4 myosin cross bridges per the 12 actin cooperative unit size, as suggested by Lehrer and Geeves (8). Thus by altering the myosin concentration on the motility surface, myosin strong-binding activation of the filament can be investigated. Myosin binding affinity to the thin filament in both solution (38) and in muscle fibers (5) is increased at low ionic strength, and therefore the effect thin filament activation by myosin strong binding is most likely enhanced in the motility assay compared with studies at physiological ionic strength (30). Consistent with these concepts, thin filament motility increased as a cooperative function of the myosin concentration on the motility surface at maximal and submaximal calcium activation. However, no difference in the activation of the thin filament by myosin strong binding was seen for the two TnT isoforms.
Fetal cardiac fibers are less affected by acidic condition compared with adult cardiac fibers (29), raising the possibility that TnT isoforms may respond differently to acidic conditions. Whereas unloaded shortening and cooperativity was depressed under mildly acidic conditions, no discernable difference was detected for thin filaments containing the two TnT isoforms. The above results notwithstanding, variable TnT isoform expression is most extensive in the fetal heart (2, 16, 27), suggesting a role for the TnT isoforms in the perinatal period. Furthermore, nonisoform modification of TnT is known to have significant effects on muscle contraction. There are several phosphorylation sites on TnT that are known to affect myofilament function (23, 25), and studies of TnT mutations identified in familial hypertrophic cardiomyopathy reveal significant effects on contractile function (21, 31, 32, 35).
Whereas no difference in contractile performance was delineated for the two TnT isoforms, the motility assay is not without limitations. The motiltity assay is performed in the absence of normal sarcomeric structure and is performed at lower-than-physiological ionic strength both of which could affect the results reported using this technique. Here we have used pure populations of troponin T isoforms; however, using a mixture of the two isoforms to mimic TnT isoform composition in myocardial failure and using all cardiac contractile proteins could possibly reveal subtle differences in TnT isoform performance not discovered in this study. Additional studies in myofibers and transgenically manipulated hearts where TnT isoform content is modulated might provide additional evidence regarding the effects of the cardiac TnT isoforms on contractility.
In summary, a small TnT isoform shift has been reported in human and animal models of myocardial hypertrophy and failure. We did not detect any functional difference between the two beef TnT isoforms with respect to in vitro motility or isometric force. From the small magnitude of the shift in human myocardium and the lack of a demonstrable functional mechanical effect in vitro using pure populations of TnT isoforms, it is unlikely that the TnT isoform shift reported with the transition to failure is of any functional significance.
| |
ACKNOWLEDGEMENTS |
|---|
This work was supported by the National Heart, Lung, and Blood Institute Grants HL-52087, HL-66157, HL-65586, and HL-59408.
| |
FOOTNOTES |
|---|
Address for reprint requests and other correspondence: P. VanBuren, Univ. of Vermont, College of Medicine, Dept. of Molecular Physiology and Biophysics, E215 Given Bldg., Burlington, VT 05405 (E-mail: vanburen{at}physiology.med.uvm.edu).
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
First published January 3, 2002;10.1152/ajpheart.00938.2001
Received 29 October 2001; accepted in final form 24 December 2001.
| |
REFERENCES |
|---|
|
|
|---|
1.
Anderson, PA,
Greig A,
Mark TM,
Malouf NN,
Oakeley AE,
Ungerleider RM,
Allen PD,
and
Kay BK.
Molecular basis of human cardiac troponin T isoforms expressed in the developing, adult, and failing heart.
Circ Res
76:
681-686,
1995.
2.
Anderson, PA,
Malouf NN,
Oakeley AE,
Pagani ED,
and
Allen PD.
Troponin T isoform expression in humans. A comparison among normal and failing adult heart, fetal heart, and adult and fetal skeletal muscle.
Circ Res
69:
1226-1233,
1991.
3.
Anderson, PA,
Malouf NN,
Oakeley AE,
Pagani ED,
and
Allen PD.
Troponin T isoform expression in the normal and failing human left ventricle: a correlation with myofibrillar ATPase activity.
Basic Res Cardiol
87, Suppl1:
117-127,
1992.
4.
Bing, W,
Knott A,
and
Marston SB.
A simple method for measuring the relative force exerted by myosin on actin filaments in the in vitro motility assay: evidence that tropomyosin and troponin increase force in single thin filaments.
Biochem J
350:
693-699,
2000.
5.
Brenner, B,
Schoenberg M,
Chalovich JM,
Greene LE,
and
Eisenberg E.
Evidence for cross-bridge attachment in relaxed muscle at low ionic strength.
Proc Natl Acad Sci USA
79:
7288-7291,
1982.
6.
Brooks, SP,
and
Storey KB.
Bound and determined: a computer program for making buffers of defined ion concentrations.
Anal Biochem
201:
119-126,
1992.
7.
Chen, Z,
Higashiyama A,
Yaku H,
Bell S,
Fabian J,
Watkins MW,
Schneider DJ,
Maughan DW,
and
LeWinter MM.
Altered expression of troponin T isoforms in mild left ventricular hypertrophy in the rabbit.
J Mol Cell Cardiol
29:
2345-2354,
1997.
8.
Geeves, MA,
and
Lehrer SS.
Dynamics of the muscle thin filament regulatory switch: the size of the cooperative unit.
Biophys J
67:
273-282,
1994.
9.
Guo, X,
Wattanapermpool J,
Palmiter KA,
Murphy AM,
and
Solaro RJ.
Mutagenesis of cardiac troponin I. Role of the unique NH2-terminal peptide in myofilament activation.
J Biol Chem
269:
15210-15216,
1994.
10.
Haeberle, JR.
Calponin decreases the rate of cross-bridge cycling and increases maximum force production by smooth muscle myosin in an in vitro motility assay.
J Biol Chem
269:
12424-12431,
1994.
11.
Harris, DE,
and
Warshaw DM.
Smooth and skeletal muscle myosin both exhibit low duty cycles at zero load in vitro.
J Biol Chem
268:
14764-14768,
1993.
12.
Hinkle, A,
Goranson A,
Butters CA,
and
Tobacman LS.
Roles for the troponin tail domain in thin filament assembly and regulation. A deletional study of cardiac troponin T.
J Biol Chem
274:
7157-7164,
1999.
13.
Homsher, E,
Kim B,
Bobkova A,
and
Tobacman LS.
Calcium regulation of thin filament movement in an in vitro motility assay.
Biophys J
70:
1881-1892,
1996.
14.
Homsher, E,
Wang F,
and
Sellers JR.
Factors affecting movement of F-actin filaments propelled by skeletal muscle heavy meromyosin.
Am J Physiol Cell Physiol
262:
C714-C723,
1992.
15.
Huang, QQ,
Brozovich FV,
and
Jin JP.
Fast skeletal muscle troponin T increases the cooperativity of transgenic mouse cardiac muscle contraction.
J Physiol (Lond)
520:
231-242,
1999.
16.
Jin, JP.
Alternative RNA splicing-generated cardiac troponin T isoform switching: a non-heart-restricted genetic programming synchronized in developing cardiac and skeletal muscles.
Biochem Biophys Res Commun
225:
883-889,
1996.
17.
Jin, JP,
and
Lin JJ.
Rapid purification of mammalian cardiac troponin T and its isoform switching in rat hearts during development.
J Biol Chem
263:
7309-7315,
1988.
18.
Kameyama, T,
Chen Z,
Bell SP,
VanBuren P,
Maughan D,
and
LeWinter MM.
Mechanoenergetic alterations during the transition from cardiac hypertrophy to failure in Dahl salt-sensitive rats.
Circulation
98:
2919-2929,
1998.
19.
Lehman, W,
Vibert P,
Uman P,
and
Craig R.
Steric-blocking by tropomyosin visualized in relaxed vertebrate muscle thin filaments.
J Mol Biol
251:
191-196,
1995.
20.
Leszyk, J,
Dumaswala R,
Potter JD,
Gusev NB,
Verin AD,
Tobacman LS,
and
Collins JH.
Bovine cardiac troponin T: amino acid sequences of the two isoforms.
Biochemistry
26:
7035-7042,
1987.
21.
Lin, D,
Bobkova A,
Homsher E,
and
Tobacman LS.
Altered cardiac troponin T in vitro function in the presence of a mutation implicated in familial hypertrophic cardiomyopathy.
J Clin Invest
97:
2842-2848,
1996.
22.
Margossian, SS,
and
Lowey S.
Preparation of myosin and its subfragments from rabbit skeletal muscle.
Methods Enzymol
85:
55-71,
1982.
23.
Noland, TAJ,
and
Kuo JF.
Protein kinase C phosphorylation of cardiac troponin T decreases Ca(2+)-dependent actomyosin MgATPase activity and troponin T binding to tropomyosin-F-actin complex.
Biochem J
288:
123-129,
1992.
24.
Pardee, JD,
and
Spudich JA.
Purification of muscle actin.
Methods Enzymol
85:
164-181,
1982.
25.
Perry, SV.
Troponin T: genetics, properties and function.
J Muscle Res Cell Motil
19:
575-602,
1998.
26.
Potter, JD.
Preparation of troponin and its subunits.
Methods Enzymol
85:
241-263,
1982.
27.
Saggin, L,
Ausoni S,
Gorza L,
Sartore S,
and
Schiaffino S.
Troponin T switching in the developing rat heart.
J Biol Chem
263:
18488-18492,
1988.
28.
Smillie, LB.
Preparation and identification of alpha- and beta-tropomyosins.
Methods Enzymol
85:
234-241,
1982.
29.
Solaro, RJ,
Kumar P,
Blanchard EM,
and
Martin AF.
Differential effects of pH on calcium activation of myofilaments of adult and perinatal dog hearts. Evidence for developmental differences in thin filament regulation.
Circ Res
58:
721-729,
1986.
30.
Swartz, DR,
and
Moss RL.
Influence of a strong-binding myosin analogue on calcium-sensitive mechanical properties of skinned skeletal muscle fibers.
J Biol Chem
267:
20497-20506,
1992.
31.
Szczesna, D,
Zhang R,
Zhao J,
Jones M,
Guzman G,
and
Potter JD.
Altered regulation of cardiac muscle contraction by troponin T mutations that cause familial hypertrophic cardiomyopathy.
J Biol Chem
275:
624-630,
2000.
32.
Tardiff, JC,
Hewett TE,
Palmer BM,
Olsson C,
Factor SM,
Moore RL,
Robbins J,
and
Leinwand LA.
Cardiac troponin T mutations result in allele-specific phenotypes in a mouse model for hypertrophic cardiomyopathy.
J Clin Invest
104:
469-481,
1999.
33.
Tobacman, LS.
Structure-function studies of the amino-terminal region of bovine cardiac troponin T.
J Biol Chem
263:
2668-2672,
1988.
34.
Tobacman, LS,
and
Lee R.
Isolation and functional comparison of bovine cardiac troponin T isoforms.
J Biol Chem
262:
4059-4064,
1987.
35.
Tobacman, LS,
Lin D,
Butters C,
Landis C,
Back N,
Pavlov D,
and
Homsher E.
Functional consequences of troponin T mutations found in hypertrophic cardiomyopathy.
J Biol Chem
274:
28363-28370,
1999.
36.
VanBuren, P,
Harris DE,
Alpert NR,
and
Warshaw DM.
Cardiac V1 and V3 myosins differ in their hydrolytic and mechanical activities in vitro.
Circ Res
77:
439-444,
1995.
37.
VanBuren, P,
Palmiter KA,
and
Warshaw DM.
Tropomyosin directly modulates actomyosin mechanical performance at the level of a single actin filament.
Proc Natl Acad Sci USA
96:
12488-12493,
1999.
38.
Williams, DLJ,
and
Greene LE.
Comparison of the effects of tropomyosin and troponin-tropomyosin on the binding of myosin subfragment 1 to actin.
Biochemistry
22:
2770-2774,
1983.
39.
Wolff, MR,
Buck SH,
Stoker SW,
Greaser ML,
and
Mentzer RM.
Myofibrillar calcium sensitivity of isometric tension is increased in human dilated cardiomyopathies: role of altered beta-adrenergically mediated protein phosphorylation.
J Clin Invest
98:
167-176,
1996.
This article has been cited by other articles:
![]() |
Y. Okada, M. J. Toth, and P. VanBuren Skeletal muscle contractile protein function is preserved in human heart failure J Appl Physiol, April 1, 2008; 104(4): 952 - 957. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Belin, M. P. Sumandea, T. Kobayashi, L. A. Walker, V. L. Rundell, D. Urboniene, M. Yuzhakova, S. H. Ruch, D. L. Geenen, R. J. Solaro, et al. Left ventricular myofilament dysfunction in rat experimental hypertrophy and congestive heart failure Am J Physiol Heart Circ Physiol, November 1, 2006; 291(5): H2344 - H2353. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Nassar, N. N. Malouf, L. Mao, H. A. Rockman, A. E. Oakeley, J. R. Frye, J. R. Herlong, S. P. Sanders, and P. A. W. Anderson cTnT1, a cardiac troponin T isoform, decreases myofilament tension and affects the left ventricular pressure waveform Am J Physiol Heart Circ Physiol, March 1, 2005; 288(3): H1147 - H1156. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. M. Palmer, D. E. Fishbaugher, J. P. Schmitt, Y. Wang, N. R. Alpert, C. E. Seidman, J. G. Seidman, P. VanBuren, and D. W. Maughan Differential cross-bridge kinetics of FHC myosin mutations R403Q and R453C in heterozygous mouse myocardium Am J Physiol Heart Circ Physiol, July 1, 2004; 287(1): H91 - H99. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. B. Foster, T. Noguchi, P. VanBuren, A. M. Murphy, and J. E. Van Eyk C-Terminal Truncation of Cardiac Troponin I Causes Divergent Effects on ATPase and Force: Implications for the Pathophysiology of Myocardial Stunning Circ. Res., November 14, 2003; 93(10): 917 - 924. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Gorga, D. E. Fishbaugher, and P. VanBuren Activation of the Calcium-Regulated Thin Filament by Myosin Strong Binding Biophys. J., October 1, 2003; 85(4): 2484 - 2491. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. J. Biesiadecki, B. D. Elder, Z.-B. Yu, and J.-P. Jin Cardiac Troponin T Variants Produced by Aberrant Splicing of Multiple Exons in Animals with High Instances of Dilated Cardiomyopathy J. Biol. Chem., December 20, 2002; 277(52): 50275 - 50285. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. V. Gomes, G. Guzman, J. Zhao, and J. D. Potter Cardiac Troponin T Isoforms Affect the Ca2+ Sensitivity and Inhibition of Force Development. INSIGHTS INTO THE ROLE OF TROPONIN T ISOFORMS IN THE HEART J. Biol. Chem., September 13, 2002; 277(38): 35341 - 35349. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |